UNSPSC 51391614: Isometheptene hydrochloride

This classification denotes an adrenergic agent with the molecular formula C9H19N.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9Z4CJC3O5F, chemically known as 5-hepten-2-amine, n,6-dimethyl-, hydrochloride but more generally known as isometheptene hydrochloride, which bears US NIH Compound Identifier 22297. European Medicines Agency schedules Isometheptene hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB14276MIG.

Most nations, for tariff and trade purposes, schedule isometheptene hydrochloride under HS 29211980 and SITC 51451. As of Q4 2014, ISOMETHEPTENE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Isometheptene hydrochloride bears US NLM identifiers UMLS ID C2697822 and NCI Concept Code C80003. SMILES: CC(CCC=C(C)C)NC.CL.

UNSPSC 51391614 Isometheptene hydrochloride is a Commodity code that identifies a specific pharmaceutical active ingredient used in combination decongestant and pain-relief medications. State and local procurement activity under this code shows minimal volume. The single recent opportunity in the public record does not represent purchases of isometheptene hydrochloride itself; instead, Seminole County, Florida posted an IFB (IFB60459723LAS) on June 30, 2026, for Naloxone and Safe Drug Deactivation Systems—products outside this code's pharmaceutical scope. The mismatch suggests either a coding error in the county's posting or minimal genuine procurement activity for isometheptene hydrochloride at the state and local level. County health departments and community health agencies would be the typical issuing bodies for pharmaceutical purchases, but the recent-opportunities record does not support active solicitation under this code.

No representative recent opportunities exist for isometheptene hydrochloride itself. The single posted opportunity (Seminole County's naloxone procurement, due July 26, 2023, with quarterly delivery to 520 W. Lake Mary Blvd, Sanford, Florida) falls outside the code's nominal scope and does not signal demand for this specific pharmaceutical. State and local procurement professionals tracking this code should expect limited activity and focus instead on broader pharmaceutical codes or on codes specific to naloxone and opioid-reversal products if that therapeutic category aligns with their offerings.